Michael Belshan

Dr. Michael Belshan


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2012 in Retrovirology
Verified
Journal Article
Open access
PDF file
MBMichael Belshan
Michael Belshan
JKJason Kimata
Jason Kimata
CBCharles Brown
Charles Brown
XCXiaogang Cheng
Xiaogang Cheng
AMAnna McCulley
Anna McCulley
LRLee E. E. Ratner
Lee E. E. Ratner
Viral protein X (Vpx) of SIV has been reported to be important for establishing infection in vivo. Vpx has several different activities in vitro, promoting preintegration complex import into the nucleus in quiescent lymphocytes and overcoming a block in reverse transcription in macrophages. Vpx interacts with the DDB1-CUL4-DCAF1 E3 ligase complex, which may or may not be required for the ascribed functions. The goal of the current study was to determine whether these activities of Vpx are important in vivo.

2 January 2013 in Journal of Proteome Research
Verified
Journal Article
Closed access
CSCameron J. Schweitzer
Cameron J. Schweitzer
TJTeena Jagadish
Teena Jagadish
NHNicole Haverland
Nicole Haverland
PCPawel Ciborowski
Pawel Ciborowski
MBMichael Belshan
Michael Belshan

1 February 2016 in Virology
Verified
Journal Article
Closed access
JDJason DeBoer
Jason DeBoer
CMChristian J. Madson
Christian J. Madson
MBMichael Belshan
Michael Belshan

11 September 2015 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
YLYan Li
Yan Li
KFKristin M. Frederick
Kristin M. Frederick
NHNicole A. Haverland
Nicole A. Haverland
PCPawel Ciborowski
Pawel Ciborowski
MBMichael Belshan
Michael Belshan

16 February 2016 in Viruses
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
MBMichael Belshan
Michael Belshan
A previous proteomic screen in our laboratory identified nuclear factor 45 (NF45) and nuclear factor 90 (NF90) as potential cellular factors involved in human immunodeficiency virus type 1 (HIV-1) replication. Both are RNA binding proteins that regulate gene expression; and NF90 has been shown to regulate the expression of cyclin T1 which is required for Tat-dependent trans-activation of viral gene expression. In this study the roles of NF45 and NF90 in HIV replication were investigated through overexpression studies. Ectopic expression of either factor potentiated HIV infection, gene expression, and virus production. Deletion of the RNA binding domains of NF45 and NF90 diminished the enhancement of HIV infection and gene expression. Both proteins were found to interact with the HIV RNA. RNA decay assays demonstrated that NF90, but not NF45, increased the half-life of the HIV RNA. Overall, these studies indicate that both NF45 and NF90 potentiate HIV infection through their RNA binding domains.

12 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CSCameron J. Schweitzer
Cameron J. Schweitzer
JMJohn M. Matthews
John M. Matthews
CMChristian J. Madson
Christian J. Madson
MDMeghan R. Donnellan
Meghan R. Donnellan
RCRonald L. Cerny
Ronald L. Cerny
MBMichael Belshan
Michael Belshan
HIV-1 exploits numerous host cellular pathways for productive infection. To identify novel factors involved in HIV-1 replication, HIV-1 integrase and matrix protein complexes were captured at 4 hours post infection for proteomic analysis using an affinity purification system. Leucine-rich PPR-motif containing (LRPPRC) protein, a cellular protein involved in mitochondrial function, cell metabolism, and cell-cycle progression was identified as one of the candidate HIV-1 factors. Co-immunoprecipitation RT-PCR experiments confirmed that LRPPRC associated with HIV-1 nucleic acids during the early steps of virus infection. To establish if LRPPRC was critical for HIV-1 infection, three independent LRPPRC knockdown cell lines were constructed (2.7, 3.6, and 4.1). Subcellular fractionation of these cell lines revealed differential knockdown of LRPPRC in subcellular compartments. LRPPRC was knocked down in the insoluble/cytoskeletal fractions of all three cell lines, but the 3.6 and 4.1 cells also showed a reduction in nuclear LRPPRC. Additionally, several cellular factors were downregulated and/or disrupted by loss of LRPPRC. HIV-1 infection was reduced in all three cell lines, but virus production and RNA encapsidation were unaffected, suggesting that LRPPRC was critical for the afferent stage of virus replication. Two of the three cell lines (3.6, 4.1) were refractory for murine leukemia virus infection, a virus dependent on cellular proliferation for productive infection. Consistent with this, these two cell lines exhibited reduced cellular growth with no loss of cellular viability or change in cell cycle phenotype. The early steps of virus infection were also differentially affected among the cell lines. A reduced level of preintegration complex formation was observed in all three cell lines, but viral DNA nuclear import was reduced only in the 3.6 and 4.1 cells. Combined, these data identify LRPPRC as a HIV-1 factor that is involved in HIV-1 replication through more than one mechanism.